Arizona Cancer Center member named to NIH Advisory Committee

Francisco Garcia, MD, MPH
Francisco Garcia, MD, MPH

The National Institutes of Health Advisory Committee on Research on Women’s Health appointed Francisco Garcia, MD, MPH, as one of five new members.

The committee, composed of up to 18 members appointed by the NIH director, advises the Office of Research on Women's Health (ORWH) on appropriate research activities to be undertaken by the national research institutes with respect to research on women’s health; research on sex/gender differences in clinical trials, and research on women’s health conditions that require an interdisciplinary approach. Committee members are actively involved in reviewing NIH women’s health research priorities, the women’s health research portfolio for NIH, career development and the inclusion of women and minorities in clinical research.

"The wealth of diverse experiences and talents brought by these five individuals will enhance the entire committee's goal of fulfilling our ORWH mandate," said Dr. Vivian W. Pinn, director of the ORWH in a press release. "The expertise our new members bring will further enable the committee to achieve its mission of advising on those research activities that will maximize women’s health research resources, and developing innovative strategies to advance research careers."

Dr. Garcia is a member of the Arizona Cancer Center’s Cancer Prevention and Control Program and co-director of the Cancer Health Disparities Institute. He is the director of the University of Arizona Center of Excellence in Women's Health and the distinguished professor of obstetrics and gynecology, public health, pharmacy and Mexican-American studies. He is the past director and principal investigator of the Arizona Hispanic Center of Excellence as well as former director of the Division of Gynecology.

Dr. Garcia's research expertise is in the area of pre-malignant cervical disease and human papillomavirus infection and the evaluation of new technologies and therapeutics for cervical cancer precursors. Dr. Garcia also has a long established interest in the health of women on the United States-Mexico Border. He is active in the training and mentoring of residents, medical students, graduate students and international medical personnel interested in women's health.

For more information: visit http://www.nih.gov/news/health/jul2010/od-20.htm